USFDA issues EIR for Alkem Laboratories’ St. Louis facility

12 Sep 2019 Evaluate

US Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) for Alkem Laboratories’ manufacturing facility located at St. Louis, Fenton Logistics Park, USA which was inspected from August 16, 2019 to August 22, 2019 and where the Company received a Form 483 issued by the USFDA containing four observations.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Alkem Laboratories Share Price

5733.45 75.65 (1.34%)
22-Jan-2026 13:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1617.25
Dr. Reddys Lab 1216.85
Cipla 1372.40
Zydus Lifesciences 884.55
Lupin 2172.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×